drugset
drugset / Trial / NCT01982604

Comparison of 30 Units of TI (Technosphere® Insulin) Prepared With Insulin From Two Different Suppliers

NCT01982604 ↗

Phase 1 Completed 38 enrolled Mannkind Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

A Phase 1, open-label randomized crossover trial in Healthy Volunteers to evaluate the PK/PD of TI (Technosphere® Insulin) prepared with insulin from two different suppliers.

Timeline

Start
2013-11
Primary completion
2014-02
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject TI-Inhalation Powder A Unknown 30 iu Inhaled
Subject TI-Inhalation Powder B Unknown 30 iu Inhaled

Indications

No indication recorded.